Retinal layers changes in human preclinical and early clinical diabetic retinopathy support early retinal neuronal and müller cells alterations

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Vujosevic, Stela ^a   Midena, Edoardo ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; EYE EXAMINATION; EYE PHOTOGRAPHY; FEMALE; HUMAN; INNER MACULAR RETINAL LAYER THICKNESS; MAJOR CLINICAL STUDY; MALE; MUELLER CELL; OUTER MACULAR RETINAL LAYER THICKNESS; PERIPAPILLARY RETINAL LAYER THICKNESS; PRIORITY JOURNAL; REFRACTION ERROR; RETINA GANGLION CELL; RETINA INNER PLEXIFORM LAYER; RETINA NERVE CELL; RETINAL NERVE FIBER LAYER THICKNESS; RETINAL THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; STEREOSCOPIC FUNDUS PHOTOGRAPHY; VISUAL ACUITY; AGED; CELL PROLIFERATION; DISEASE COURSE; MACROGLIA; MACULAR EDEMA; MIDDLE AGED; PATHOLOGY; RETINA; RETINA MACULA EDEMA;

ADULT; AGED; CELL PROLIFERATION; DIABETIC RETINOPATHY; DISEASE PROGRESSION; EPENDYMOGLIAL CELLS; FEMALE; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINA; RETINAL NEURONS;

EID: 84880148705     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/905058     Document Type: Article

References (41)

1. Girach A., Manner D., Porta M., Diabetic microvascular complications: can patients at risk be identified? A review. International Journal of Clinical Practice 2006 60 11 1471 1483 2-s2.0-33749821010 10.1111/j.1742-1241.2006.01175. x
2. Villarroel M., Ciudin A., Hernandez C., Simo R., Neurodegeneration: an early event of diabetic retinopathy. World Journal of Diabetes 2010 1 57 64
3. Antonetti D. A., Klein R., Gardner T. W., Diabetic retinopathy. The New England Journal of Medicine 2012 366 13 1227 1239 2-s2.0-84859012407 10.1056/NEJMra1005073
4. Barber A. J., Gardner T. W., Abcouwer S. F., The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Investigative Ophthalmology and Visual Science 2011 52 2 1156 1163 2-s2.0-79953269159 10.1167/iovs.10-6293
5. Midena E., Segato T., Giuliano M., Zucchetto M., Macular recovery function (nyctometry) in diabetics without and with early retinopathy. British Journal of Ophthalmology 1990 74 2 106 108 2-s2.0-0025128750
6. Midena E., Vujosevic S., Tink J. T., Barnstable C. J., Gardner T. W., Visual psychophysics in diabetic retinopathy. Visual Disfunction in Diabetes 2012 New York, NY, USA Springer 69 105
7. Kern T. S., Barber A. J., Retinal ganglion cells in diabetes. Journal of Physiology 2008 586 18 4401 4408 2-s2.0-51849157860 10.1113/jphysiol.2008.156695
8. Gastinger M. J., Singh R. S. J., Barber A. J., Loss of cholinergic and dopaminergic amacrine cells in streptozotocin- diabetic rat and Ins2Akita-diabetic mouse retinas. Investigative Ophthalmology and Visual Science 2006 47 7 3143 3150 2-s2.0-33746729952 10.1167/iovs.05-1376
9. Ly A., Yee P., Vessey K. A., Phipps J. A., Jobling A. I., Fletcher E. L., Early inner retinal astrocyte dysfunction during diabetes and development of hypoxia, retinal stress,and neuronal functional loss. Investigative Ophthalmology and Visual Science 2011 52 13 9316 9326 2-s2.0-82955213965 10.1167/iovs.11-7879
10. Biallosterski C., Van Velthoven M. E. J., Michels R. P. J., Schlingemann R. O., DeVries J. H., Verbraak F. D., Decreased optical coherence tomography-measured pericentral retinal thickness in patients with diabetes mellitus type 1 with minimal diabetic retinopathy. British Journal of Ophthalmology 2007 91 9 1135 1138 2-s2.0-34548308663 10.1136/bjo.2006.111534
11. Browning D. J., Fraser C. M., Clark S., The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema. Ophthalmology 2008 115 3 533 539 2-s2.0-39949085613 10.1016/j.ophtha.2007.06.042
12. Nilsson M., Von Wendt G., Wanger P., Martin L., Early detection of macular changes in patients with diabetes using Rarebit Fovea Test and optical coherence tomography. British Journal of Ophthalmology 2007 91 12 1596 1598 2-s2.0-36749078181 10.1136/bjo.2007.124461
13. Oshitari T., Hanawa K., Adachi-Usami E., Changes of macular and RNFL thicknesses measured by Stratus OCT in patients with early stage diabetes. Eye 2009 23 4 884 889 2-s2.0-65349163406 10.1038/eye.2008.119
14. Van Dijk H. W., Verbraak F. D., Kok P. H. B., Garvin M. K., Sonka M., Lee K., Devries J. H., Michels R. P. J., van Velthoven M. E. J., Schlingemann R. O., Abràmoff M. D., Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Investigative Ophthalmology and Visual Science 2010 51 7 3660 3665 2-s2.0-77955865169 10.1167/iovs.09-5041
15. Van Dijk H. W., Kok P. H. B., Garvin M., Sonka M., Hans Devries J., Michels R. P. J., van Velthoven M. E. J., Schlingemann R. O., Verbraak F. D., Abràmoff M. D., Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Investigative Ophthalmology and Visual Science 2009 50 7 3404 3409 2-s2.0-67649977021 10.1167/iovs.08-3143
16. Ferris F. L. III, Kassoff A., Bresnick G. H., Bailey L., New visual acuity charts for clinical research. American Journal of Ophthalmology 1982 94 1 91 96 2-s2.0-0019988950
17. Bringmann A., Iandiev I., Pannicke T., Wurm A., Hollborn M., Wiedemann P., Osborne N. N., Reichenbach A., Cellular signaling and factors involved in Müller cell gliosis: neuroprotective and detrimental effects. Progress in Retinal and Eye Research 2009 28 6 423 451 2-s2.0-70350423565 10.1016/j.preteyeres.2009.07.001
18. Bringmann A., Wiedemann P., Müller glial cells in retinal disease. Ophthalmologica 2011 227 1 1 19 2-s2.0-84155163254 10.1159/000328979
19. Joussen A. M., Poulaki V., Le M. L., Koizumi K., Esser C., Janicki H., Schraermeyer U., Kociok N., Fauser S., Kirchhof B., Kern T. S., Adamis A. P., A central role for inflammation in the pathogenesis of diabetic retinopathy. The FASEB Journal 2004 18 12 1450 1452 2-s2.0-7044228789 10.1096/fj.03-1476fje
20. Ibrahim A. S., El-Remessy A. B., Matragoon S., Zhang W., Patel Y., Khan S., Al-Gayyar M. M., El-Shishtawy M. M., Liou G. I., Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes. Diabetes 2011 60 4 1122 1133 2-s2.0-79953188707 10.2337/db10-1160
21. DeBuc D. C., Somfai G. M., Early detection of retinal thickness changes in diabetes using optical coherence tomography. Medical Science Monitor 2010 16 3 MT15 MT21 2-s2.0-77649250409
22. Cabrera Fernández D., Somfai G. M., Tátrai E., Potentiality of intraretinal layer segmentation to locally detect early retinal changes in patients with diabetes mellitus using optical coherence tomography. Investigative Ophthalmology & Visual Science 2008 49
23. Lopes de Faria J. M., Russ H., Costa V. P., Retinal nerve fibre layer loss in patients with type 1 diabetes mellitus without retinopathy. British Journal of Ophthalmology 2002 86 7 725 728 2-s2.0-0036296390 10.1136/bjo.86.7.725
24. Takahashi H., Goto T., Shoji T., Tanito M., Park M., Chihara E., Diabetes-associated retinal nerve fiber damage evaluated with scanning laser polarimetry. American Journal of Ophthalmology 2006 142 1 88 94 2-s2.0-33745422509 10.1016/j.ajo.2006.02.016
25. Sugimoto M., Sasoh M., Ido M., Wakitani Y., Takahashi C., Uji Y., Detection of early diabetic change with optical coherence tomography in type 2 diabetes mellitus patients without retinopathy. Ophthalmologica 2005 219 6 379 385 2-s2.0-27744465199 10.1159/000088382
26. Peng P.-H., Lin H.-S., Lin S., Nerve fibre layer thinning in patients with preclinical retinopathy. Canadian Journal of Ophthalmology 2009 44 4 417 422 2-s2.0-68149159047 10.3129/i09-112
27. Lonneville Y. H., Ozdek S. C., Onol M., Yetkin I., Gürelik G., Hasanreisoǧlu B., The effect of blood glucose regulation on retinal nerve fiber layer thickness in diabetic patients. Ophthalmologica 2003 217 347 350
28. Rungger-Brändle E., Dosso A. A., Leuenberger P. M., Glial reactivity, an early feature of diabetic retinopathy. Investigative Ophthalmology & Visual Science 2000 41 1971 1980
29. Li Q., Puro D. G., Diabetes-induced dysfunction of the glutamate transporter in retinal Müller cells. Investigative Ophthalmology & Visual Science 2002 43 3109 3116
30. Lieth E., Barber A. J., Xu B., Dice C., Ratz M. J., Tanase D., Strother J. M., Glial reactivity and impaired glutamate metabolism in short- term experimental diabetic retinopathy. Diabetes 1998 47 7 815 820 2-s2.0-0031780346
31. Mizutani M., Gerhardinger C., Lorenzi M., Muller cell changes in human diabetic retinopathy. Diabetes 1998 47 3 445 449 2-s2.0-0031594369 10.2337/diabetes.47.3.445
32. Zeng X.-X., Ng Y.-K., Ling E.-A., Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Visual Neuroscience 2000 17 3 463 471 2-s2.0-0033921527 10.1017/S0952523800173122
33. Puro D. G., Diabetes-induced dysfunction of retinal Müller cells. Transactions of the American Ophthalmological Society 2002 100 339 352
34. Curtis T. M., Hamilton R., Yong P.-H., McVicar C. M., Berner A., Pringle R., Uchida K., Nagai R., Brockbank S., Stitt A. W., Müller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products. Diabetologia 2011 54 3 690 698 2-s2.0-79953732125 10.1007/s00125-010-1971-x
35. Yong P. H., Zong H., Medina R. J., Limb G. A., Uchida K., Stitt A. W., Curtis T. M., Evidence supporting a role for N ε -(3-formyl-3,4- dehydropiperidino)lysine accumulation in Müller glia dysfunction and death in diabetic retinopathy. Molecular Vision 2010 16 2524 2538 2-s2.0-78650781342
36. Reichenbach A., Wurm A., Pannicke T., Iandiev I., Wiedemann P., Bringmann A., Müller cells as players in retinal degeneration and edema. Graefe's Archive for Clinical and Experimental Ophthalmology 2007 245 5 627 636 2-s2.0-34250728189 10.1007/s00417-006-0516-y
37. Van Dijk H. W., Verbraak F. D., Kok P. H. B., Early neurodegeneration in the retina of type 2 diabetic patients. Investigative Ophthalmology & Visual Science 2012 53 2715 2719
38. Gardner T. W., Antonetti D. A., Barber A. J., LaNoue K. F., Levison S. W., Diabetic retinopathy: more than meets the eye. Survey of Ophthalmology 2002 47 2 S253 S262 2-s2.0-0036943831 10.1016/S0039-6257(02)00387-9
39. Carrasco E., Hernández C., Miralles A., Huguet P., Farrés J., Simó R., Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration. Diabetes Care 2007 30 11 2902 2908 2-s2.0-36048980250 10.2337/dc07-0332
40. Carrasco E., Hernández C., de Torres I., Farrés J., Simó R., Lowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activation. Molecular Vision 2008 14 1496 1502 2-s2.0-50249171613
41. Fortune B., Yang H., Strouthidis N. G., Cull G. A., Grimm J. L., Downs J. C., Burgoyne C. F., The effect of acute intraocular pressure elevation on peripapillary retinal thickness, retinal nerve fiber layer thickness, and retardance. Investigative Ophthalmology and Visual Science 2009 50 10 4719 4726 2-s2.0-70349582728 10.1167/iovs.08-3289